Predicting risk of breast cancer in postmenopausal women by hormone receptor status (Q46901894)

26 December 2017

title

Predicting risk of breast cancer in postmenopausal women by hormone receptor status (English)

1 reference

26 December 2017

Women's Health Initiative Investigators

author

10

object named as

Women's Health Initiative Investigators

1 reference

26 December 2017

Rowan T Chlebowski

1

object named as

Rowan T Chlebowski

1 reference

26 December 2017

author name string

Garnet L Anderson

2

1 reference

26 December 2017

Dorothy S Lane

3

1 reference

26 December 2017

Aaron K Aragaki

4

1 reference

26 December 2017

Thomas Rohan

5

1 reference

26 December 2017

Shagufta Yasmeen

6

1 reference

26 December 2017

Gloria Sarto

7

1 reference

26 December 2017

Carol A Rosenberg

8

1 reference

26 December 2017

F Allan Hubbell

9

1 reference

26 December 2017

language of work or name

English

0 references

publication date

13 November 2007

1 reference

26 December 2017

Journal of the National Cancer Institute

published in

1 reference

26 December 2017

volume

99

1 reference

26 December 2017

issue

22

1 reference

26 December 2017

page(s)

1695-1705

1 reference

26 December 2017

Validation studies for models projecting the risk of invasive and total breast cancer incidence

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Cancer risk prediction models: a workshop on development, evaluation, and application

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Breast cancer risk in primary care: implications for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Implementation of the women's health initiative study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

The Women's Health Initiative recruitment methods and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

The women's health initiative observational study: baseline characteristics of participants and reliability of baseline measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

A comparison of goodness-of-fit tests for the logistic regression model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Validation of a breast cancer risk assessment model in women with a positive family history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Validation of the Gail et al. model for predicting individual breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Risk factors for breast cancer according to estrogen and progesterone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Breast biopsy utilization: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Risk Factors for Hormone Receptor-Defined Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Breast cancer risk assessment models: applicability to African-American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Benign breast disease and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

21 January 2018

Benign breast disorders

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Premalignant and in situ breast disease: biology and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Serum estradiol level and risk of breast cancer during treatment with raloxifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM224

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJM224

1 reference

26 December 2017

1 reference

26 December 2017